• Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Authors Posts by Watertime

Watertime

255 POSTS 0 COMMENTS

East Forest IN THE PORTAL DOME

Samskara Film & Discussion w/ Android Jones IN THE PORTAL DOME

Can a State Fast-Track a Psychedelic Breakthrough? Inside Texas’ Plan to...

Gilgamesh’s Next-Gen Psychedelic GM-2505 Prints Impressive Results in Phase 2a Major...

Jeff Breau – Exploring Psychedelic Churches at Harvard Divinity School

Matt Zorn, the Government’s Former Adversary, Is Now Its Psychedelics Czar

Pα+ Psychedelic Bulletin #198: New Data Offers Look at Spravato’s Long-Term...

Psychedelics in Japan: Dr. Hiroyuki Uchida on Studies, Stigma, and the...

Paul Gillis-Smith – Psychedelics, Religion & Lisa Bieberman

FDA’s Makary Hints at Faster Reviews for Psychedelic Therapies

1...678...26Page 7 of 26

EDITOR PICKS

Advanced Shadow Work and Psychedelic Integration: A Jungian Path to Wholeness

Essentials of Psychedelic Therapy & Integration

Pα+ Psychedelic Bulletin #206: Q2’25 Psychedelic Lobbying; Tabernanthalog’s Neuroplasticity Pathway; UK...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    ©